0
Study | ONLINE FIRST

Evaluation of Clinical Results, Histological Architecture, and Collagen Expression Following Treatment of Mature Burn Scars With a Fractional Carbon Dioxide Laser

David M. Ozog, MD; Austin Liu, MD; Marsha L. Chaffins, MD; Adrian H. Ormsby, MD; Edgar F. Fincher, MD, PhD; Lisa K. Chipps, MD; Qing-Sheng Mi, MD, PhD; Peter H. Grossman, MD; John C. Pui, MD; Ronald L. Moy, MD
JAMA Dermatol. 2013;149(1):50-57. doi:10.1001/2013.jamadermatol.668.
Text Size: A A A
Published online

Objective  To assess mature burn scars treated with a fractional carbon dioxide laser for changes in histological architecture, type I to III collagen ratios, density of elastic tissue, and subjective measures of clinical improvements.

Design  Uncontrolled, prospective study of patients with mature burn scars, from a clinical and histological perspective. Biopsy specimens were obtained before and 2 months after 3 treatment sessions. The tissue was prepared with Verhoff von Giesen (VVG) stain to discern elastic tissue and Herovici stain to differentiate types I and III collagen.

Setting  Subjects were recruited from the Grossman Burn Centers.

Participants  Of 18 patients with mature burn scars, 10 completed the entire treatment protocol.

Intervention  Participants received 3 treatments with a fractional carbon dioxide laser.

Main Outcome Measures  Vancouver Scar Scale and Patient and Observer Scar Assessment Scale survey scores. In histological analysis, imaging software was used to measure changes in collagen subtype and elastic tissue. A rating scale was developed to assess normal vs scar architecture.

Results  The first hypothesis that significant histological improvement would occur and the second hypothesis of a statistically significant increase in type III collagen expression or a decrease in type I collagen expression were confirmed. There were no significant changes in elastic tissue. Statistically significant improvements were seen in all survey data.

Conclusions  Treatment with a fractional carbon dioxide laser improved the appearance of mature burn scars and resulted in a significant improvement in collagen architecture following treatment. Furthermore, in treated skin specimens, a collagen subtype (types I and III collagen) profile resembling that of nonwounded skin was found.

Figures in this Article

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Place holder to copy figure label and caption
Grahic Jump Location

Figure 1. Vancouver Scar Scale questionnaire used in our study. The questionnaire includes assessment of vascularity, pigmentation, pliability, and height.

Place holder to copy figure label and caption
Grahic Jump Location

Figure 2. Patient and Observer Scar Assessment Scale10 used in our study. Hypo indicates hypopigmentation; hyper, hyperpigmentation.

Place holder to copy figure label and caption
Grahic Jump Location

Figure 3. Flowchart demonstrating participant accrual to the study.

Place holder to copy figure label and caption
Grahic Jump Location

Figure 4. Statistically significant improvement in pretreatment and posttreatment Vancouver Scar Scale observer scores (Wilcoxon signed rank test, P = .002).

Place holder to copy figure label and caption
Grahic Jump Location

Figure 5. Clinical photographs of a mature burn scar before (A) and after (B) 3 treatments with the fractional carbon dioxide laser.

Place holder to copy figure label and caption
Grahic Jump Location

Figure 6. Patient and Observer Scar Assessment Scale scores. There was statistically significant improvement in pretreatment and posttreatment Patient (Wilcoxon signed rank test, P = .002) (A) and Observer (Wilcoxon signed rank test, P = .004) (B) Scar Assessment Scale scores.

Place holder to copy figure label and caption
Grahic Jump Location

Figure 7. Herovici-stained specimen. Note the shift from type I collagen (red) predominance before fractional carbon dioxide laser treatment (A) to type III collagen (blue) after treatment (B) (original magnification ×20).

Place holder to copy figure label and caption
Grahic Jump Location

Figure 8. Hematoxylin-eosin–stained specimen. There is significant improvement in dermal collagen from pretreatment (A) to posttreatment (B) specimens, which have finer and more fibrillar collagen (original magnification ×20).

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Jobs